share_log

Kong Lam Buys Handful Of Shares In China Medical System Holdings

Kong Lam Buys Handful Of Shares In China Medical System Holdings

康南購買中國醫療系統控股有限公司少量股份
Simply Wall St ·  08/28 18:15

Potential China Medical System Holdings Limited (HKG:867) shareholders may wish to note that the Founder, Kong Lam, recently bought HK$3.6m worth of stock, paying HK$7.23 for each share. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

中國醫療系統控股有限公司(HKG:867)的潛在股東可能希望注意到,創始人Kong Lam最近購買了價值360萬港元的股票,每股支付7.23港元。儘管這筆交易在百分比或絕對價值上都不算太大,但可以看作是一個好兆頭。

China Medical System Holdings Insider Transactions Over The Last Year

中國醫療系統控股內部交易在過去一年內

In fact, the recent purchase by Founder Kong Lam was not their only acquisition of China Medical System Holdings shares this year. Earlier in the year, they paid HK$7.32 per share in a HK$7.3m purchase. That means that an insider was happy to buy shares at above the current price of HK$7.19. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Kong Lam was the only individual insider to buy shares in the last twelve months.

事實上,創始人Kong Lam最近的買入並不是他們今年對中國醫療系統控股的唯一買入。在年初,他們以7.32港元每股的價格購買了價值730萬港元的股票。這意味着內部人士樂意以高於當前7.19港元的價格購買股票。他們的觀點可能自那時起就已經改變,但至少表明他們當時感到樂觀。對我們來說,考慮內部人士購買股票時的價格是非常重要的。一般來說,當內部人士以高於當前價格購買股票時,我們對股票的看法更爲積極,因爲這表明他們認爲股票的價值較高,即使價格更高。Kong Lam是過去12個月內唯一一個買入股票的個人內部人士。

Kong Lam bought a total of 21.00m shares over the year at an average price of HK$7.05. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

Kong Lam在過去一年內以平均7.05港元的價格購買了2100萬股。您可以在下面看到內部交易(由公司和個人)過去12個月的視覺呈現。如果您點擊圖表,就可以看到所有的個人交易,包括股價、個人和日期!

1724883338485
SEHK:867 Insider Trading Volume August 28th 2024
SEHK:867內部人交易成交量2024年8月28日

There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).

內部人士正在購買的股票是無數的。如果您喜歡投資於較少知名公司,您可以查看此免費的公司列表(提示:內部人士一直在購買它們)。

Insider Ownership Of China Medical System Holdings

中國醫療系統控股內部持股情況

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that China Medical System Holdings insiders own 51% of the company, worth about HK$8.9b. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

許多投資者喜歡查看公司被內部人持有的比例。通常來說,內部人持股比例越高,內部人就越有動力長期發展公司。很高興看到中國醫療系統控股的內部人擁有公司51%的股份,價值約89億港元。大多數股東都會樂意看到這種內部持股情況,因爲這表明管理層的激勵與其他股東的利益是一致的。

So What Does This Data Suggest About China Medical System Holdings Insiders?

那麼這些數據對中國醫藥系統控股有限公司內部人員意味着什麼?

It is good to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest China Medical System Holdings insiders are well aligned, and quite possibly think the share price is too low. One for the watchlist, at least! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, we've identified 2 warning signs with China Medical System Holdings and understanding them should be part of your investment process.

近期內部人購買股份情況看起來不錯。對過去一年的交易進行分析也增加了我們的信心。當結合顯著的內部持股情況時,這些因素表明中國醫療系統控股的內部人利益是相符的,很可能認爲股價偏低。至少要加入自選名單!儘管了解內部人的持股和交易情況很重要,但在做出任何投資決定之前,我們一定要考慮股票面臨的風險。在投資風險方面,我們已經發現了中國醫療系統控股的2個警示信號,了解這些信號應該是你投資過程的一部分。

Of course China Medical System Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,中國醫療系統控股可能不是最好的股票選擇。因此,你可能希望看看這些高質量公司的免費收藏。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論